DONALD KOTRADY has been elected president of the Austin (Tex.) Symphony Board of Directors, succeeding THOMAS M. NEVILLE. Currently a member of the Lakeway Zoning and Planning Commission, Kotrady spent 30 years as an executive with the Wilmington, Delaware-based chemical firm Astra-Zeneca. He has been active with the Austin Symphony since relocating to Texas in 1995, including service on the board’s Business Gifts Committee.
Posted December 15, 2015